|
Intel
supports urgent call for UK-wide collaboration to find new solutions for
the management of chronic disease
LONDON
, UK
, July 19, 2007 – At a summit hosted by Intel Corporation today, a
group of healthcare experts and decision-makers debated solutions that
could improve care for people with chronic disease and ease the strain
on patients, their families and the NHS. Participants challenged each
other on ways of improving the quality and integration of patient care
including the role technology can play in reducing the cost burden.
Vice President and General Manager of Intel’s Digital Health Group,
Louis Burns said: “The rise in chronic diseases such as diabetes,
heart failure and pulmonary disease combined with an ever ageing
population will put an increased social and economic strain on the
healthcare system. This summit was to facilitate a ‘meeting of
minds’ to debate the issues and promote engagement between patients,
carers, healthcare professionals and policy makers.”
The care of people with chronic conditions consumes a large proportion
of health and social care resources.
With the incidence of chronic disease in the over 65s estimated to
double by 2030,
[i]
the UK healthcare system is facing a significant challenge.
In the UK, it is estimated that seventeen and a half million people live
with a chronic conditioni
and around 80% of GP consultations relate to chronic disease.i
By 2015, almost five million people in the UK will die from a chronic
disease, with a cost to the UK economy of £18.8 billion (US$33 billion
dollars).
[ii]
David Kelly, Director, West Lothian Community Health and Care
Partnership, one of the panelists said: “To care for the growing
ageing and chronically ill populations, we must embrace new ways of
offering care and extending it further into the community and
individuals’ homes. I share Intel’s view for driving change
– a collaborative effort across healthcare, business and policy
leaders must be established.”
Intel’s Commitment to Personal
Telehealth
Intel’s years of health research to understand the needs of the
worldwide ageing population has laid the foundation for its product
development for the ageing and chronically ill. The products under
development are based on the real needs of the ageing populations and
their
carers
and healthcare providers that Intel has discovered through ethnographic
research.
In addition to developing products, Intel is helping create a large
marketplace of interoperable personal
telehealth
devices and services through the Continua Health Alliance. Through
Intel’s collaboration in Continua and other efforts, it is trying to
ease adoption barriers including regulatory, reimbursement and policy.
Summit Participants Come from all Aspects of Healthcare
Participants in the Chronic Care at the Crossroads summit, held
at the Royal College of Physicians, included healthcare professionals
and
organisations
focused on the needs of patients and
carers
. While they debated many of the solutions, there was a unifying call
for a paradigm shift from today’s reactive model of care to one that
enables a proactive, continuous and integrated approach to improving
patient health while reducing stress to the healthcare system, the
patient and their family members.
At the
Chronic Care at the Crossroads
summit, Jeremy Vine, the BBC broadcaster, moderated three panel
discussions, with question and answer sessions – bringing together 10
healthcare experts, including representatives from NHS Connecting for
Health, The Research Institute for the Care of the Elderly (RICE), and
the UK eHealth Association and others.
For more information about what Intel is doing in healthcare, visit
www.intel.com/healthcare.
A meeting report of the Chronic Care at the Crossroads summit will also
be available on this website next month. To learn more about the
Continua Health Alliance, visit www.continuaalliance.org/home.
Intel, the world leader in silicon innovation, develops technologies,
products and initiatives to continually advance how people work and
live. Additional information about Intel is available at www.intel.com/pressroom.
– 30 –
Intel and the Intel logo are trademarks of Intel Corporation or its
subsidiaries in the United States and other countries.
* Other names and brands may be claimed as the property of others.
References
(21/7/07)
|